115 related articles for article (PubMed ID: 9657356)
21. Angiopoietin-2 serum levels are elevated in patients with liver cirrhosis and hepatocellular carcinoma.
Scholz A; Rehm VA; Rieke S; Derkow K; Schulz P; Neumann K; Koch I; Pascu M; Wiedenmann B; Berg T; Schott E
Am J Gastroenterol; 2007 Nov; 102(11):2471-81. PubMed ID: 17581268
[TBL] [Abstract][Full Text] [Related]
22. Could serotonin be a potential marker for hepatocellular carcinoma? A prospective single-center observational study.
Abdel-Razik A; Elhelaly R; Elzehery R; El-Diasty A; Abed S; Elhammady D; Tawfik A
Eur J Gastroenterol Hepatol; 2016 May; 28(5):599-605. PubMed ID: 26741637
[TBL] [Abstract][Full Text] [Related]
23. The significance of serum levels of adiponectin, leptin, and hyaluronic acid in hepatocellular carcinoma of cirrhotic and noncirrhotic patients.
Sadik NA; Ahmed A; Ahmed S
Hum Exp Toxicol; 2012 Apr; 31(4):311-21. PubMed ID: 22249387
[TBL] [Abstract][Full Text] [Related]
24. Plasma proteosome level as a potential marker for hepatocellular carcinoma.
Salama HM; Abdel-Haleem H; Taha FM; Abdel-Azeez RA; Marzaban RN; El-Nahaas SM; Darwish T
Arab J Gastroenterol; 2013 Sep; 14(3):87-93. PubMed ID: 24206735
[TBL] [Abstract][Full Text] [Related]
25. Relation between sex hormones and hepatocellular carcinoma.
El Mahdy Korah T; Abd Elfatah Badr E; Mohamed Emara M; Ahmed Samy Kohla M; Gamal Saad Michael G
Andrologia; 2016 Nov; 48(9):948-955. PubMed ID: 26791111
[TBL] [Abstract][Full Text] [Related]
26. Sex hormone imbalance in male alcoholic cirrhotic patients with and without hepatocellular carcinoma.
Guéchot J; Peigney N; Ballet F; Vaubourdolle M; Giboudeau J; Poupon R
Cancer; 1988 Aug; 62(4):760-2. PubMed ID: 2840190
[TBL] [Abstract][Full Text] [Related]
27. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis.
Ulu M; Alacacioglu A; Yuksel E; Pamukk BO; Bozkaya G; Ari A; Yuksel A; Sop G; Alacacioglu I
Saudi J Gastroenterol; 2015; 21(1):47-50. PubMed ID: 25672239
[TBL] [Abstract][Full Text] [Related]
29. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors.
Papadopoulos V; Berkovich A; Krueger KE; Costa E; Guidotti A
Endocrinology; 1991 Sep; 129(3):1481-8. PubMed ID: 1651852
[TBL] [Abstract][Full Text] [Related]
30. Increased IGF-I : IGFBP-3 ratio in patients with hepatocellular carcinoma.
Mattera D; Capuano G; Colao A; Pivonello R; Manguso F; Puzziello A; D'Agostino L
Clin Endocrinol (Oxf); 2003 Dec; 59(6):699-706. PubMed ID: 14974910
[TBL] [Abstract][Full Text] [Related]
31. Serum PAI-1 and PAI-1 4G/5G Polymorphism in Hepatitis C Virus-Induced Cirrhosis and Hepatitis C Virus-Induced Hepatocellular Carcinoma Patients.
El Edel RH; Essa ES; Essa AS; Hegazy SA; El Rowedy DI
Viral Immunol; 2016 Nov; 29(9):510-515. PubMed ID: 27459171
[TBL] [Abstract][Full Text] [Related]
32. Increased serum granulocyte colony stimulating factor in Turkish hepatocellular carcinoma patients.
Kaya AO; Coskun U; Sancak B; Buyukberber S; Yildiz R; Gulbahar O; Benekli M; Ozenirler S
Asian Pac J Cancer Prev; 2009; 10(3):403-6. PubMed ID: 19640182
[TBL] [Abstract][Full Text] [Related]
33. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat.
Bovolin P; Schlichting J; Miyata M; Ferrarese C; Guidotti A; Alho H
Regul Pept; 1990 Jul; 29(2-3):267-81. PubMed ID: 2171047
[TBL] [Abstract][Full Text] [Related]
34. Elevation of serum MAGE-4 protein levels and prediction of hepatocellular carcinogenesis in patients with liver cirrhosis.
Yutani S; Tanaka M; Mutsumoto H; Imai N; Sata M; Shichijo S; Harada M; Itoh K
Jpn J Cancer Res; 2002 Apr; 93(4):453-8. PubMed ID: 11985796
[TBL] [Abstract][Full Text] [Related]
35. Serum amino acid levels in patients with hepatocellular carcinoma.
Watanabe A; Higashi T; Sakata T; Nagashima H
Cancer; 1984 Nov; 54(9):1875-82. PubMed ID: 6090002
[TBL] [Abstract][Full Text] [Related]
36. The levels of ghrelin, leptin, TNF-alpha, and IL-6 in liver cirrhosis and hepatocellular carcinoma due to HBV and HDV infection.
Ataseven H; Bahcecioglu IH; Kuzu N; Yalniz M; Celebi S; Erensoy A; Ustundag B
Mediators Inflamm; 2006; 2006(4):78380. PubMed ID: 17047295
[TBL] [Abstract][Full Text] [Related]
37. Serum lipids in hepatoma.
Alsabti EA
Oncology; 1979; 36(1):11-4. PubMed ID: 221872
[TBL] [Abstract][Full Text] [Related]
38. Risk and predictors of hepatocellular carcinoma for chronic hepatitis B patients with newly developed cirrhosis.
Chien J; Liu J; Lee MH; Jen CL; Batrla-Utermann R; Lu SN; Wang LY; You SL; Yang HI; Chen CJ
J Gastroenterol Hepatol; 2016 Dec; 31(12):1971-1977. PubMed ID: 27118149
[TBL] [Abstract][Full Text] [Related]
39. Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alpha-fetoprotein.
Iacovazzi PA; Trisolini A; Barletta D; Elba S; Manghisi OG; Correale M
Clin Chem Lab Med; 2001 Oct; 39(10):961-5. PubMed ID: 11758611
[TBL] [Abstract][Full Text] [Related]
40. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
